Company intelligence / Profile preview

Van Hessen

Nieuwerkerk aan den IJssel, Zuid-Holland, Netherlandsvanhessen.com ↗

Ownership: Private
Development stage: Other

Overview

Van Hessen supplies globally sourced animal-derived raw materials used as active pharmaceutical ingredients in commercial medicines such as heparin and chondroitin. The company operates a fully integrated supply chain with traceability and quality control at all stages. It does not develop finished drugs or conduct clinical trials itself but provides essential starting materials to the pharma industry.

Therapeutic areas: GastroenterologyRheumatologyHematology
Modalities: Active pharmaceutical ingredient (API) raw materials from animal originBiologic (animal-derived mucosa for heparin)Protein (pancreatic enzymes)Polysaccharide (chondroitin from cartilage)
Industry: Chemicals & Materials

Partnerships

Bioiberica

Beyond the preview

Go deeper on Van Hessen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Van Hessen.

Explore the full profile